Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Dow Jones Slides 250 Points Amid Housing Data; DraftKings Pops On Upgrade

The Dow Jones slid 250 points Tuesday after key housing data. DraftKings rose on an analyst upgrade, while Tesla stock skidded.

Investors Business Daily

Dow Jones Futures Fall: Key Inflation Data Looms As Yields Jump; Tesla Stock In Focus Ahead Of Deliveries

Dow Jones futures: Key inflation data looms this week, while Tesla stock is in focus ahead of the EV giant's Q3 deliveries.

Investors Business Daily

Dow Jones Falls As Market Correction Worsens; 10-Year Treasury Spikes To New High

The Dow Jones Industrial Average dropped Monday, as the market correction worsens. The 10-year Treasury yield spikes to new highs.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Fall As Oil Nears $100 Per Barrel; Instacart Soars In Debut

Dow Jones fell ahead of the Fed meeting. Instacart jumped on its debut on the Nasdaq.

Investors Business Daily

3 Healthcare Stocks to Buy Today

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

StockNews.com

Amgen Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold

Amgen sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Alphabet's Wing CFO Shannon Nash shares her unique path to the C-suite

Nash, who is also an award-winning film producer, names Debbie Allen as one of her greatest mentors.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Why Amgen's $28 Billion Merger News Also Bodes Well For Pfizer, Biogen

Amgen stock rose Friday after the FTC dropped its lawsuit, clearing the way for the biotech to buy Horizon Therapeutics for $28 billion.

Investors Business Daily

The history of weight loss drugs

"It is no wonder demand for weight-loss drugs continues to soar"

Salon

Horizon Therapeutics Jumps On A New FTC Development In The Amgen Takeover Battle

The FTC pulled back one of its efforts to block Amgen's Horizon buyout, according to a document released Friday that sent HZNP stock flying on Monday.

Investors Business Daily

Amgen Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark

Amgen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 68 to 80.

Investors Business Daily

Ozempic is in the spotlight but it's just the latest in a long and strange history of weight-loss drugs

Losing weight conveniently, cheaply, safely. That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.

The Conversation

Stock Market Today: Dow Outperforms as Amgen, Boeing Gain Ground

The main benchmarks closed higher ahead of this week's key inflation update.

Kiplinger

Dow Jones Reverses Lower On Reports Of Cyberattack; Amazon Soars, Apple Plunges

The Dow Jones reversed lower Friday on reports that hospital systems in multiple states were hit by a cyberattack. Apple tanked on earnings.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rises After Jobs Report; Carl Icahn Stock Crashes 30% On Dividend Cut

The Dow Jones Industrial Average rose 190 points Friday after the July jobs report. Amazon surged on strong earnings, while Apple stock sold off. Icahn Enterprises crashed.

Investors Business Daily

Amgen Is 'Confident' It Can Wrap The Horizon Takeover By December

Amgen stock jumped Friday after topping Wall Street's second-quarter views, but investors remain zeroed in on the takeover of Horizon.

Investors Business Daily

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?

An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.

The Independent UK

Cheaper competition for Humira is hitting the market, but savings will depend on your insurance

Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree

Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.

Radio France Internationale

Jailed Dutch-Chinese scientist 'forgotten' by his country and company

Dr Zhang Mingqiang is in cell number 204 of Shanghai’s notorious Qingpu prison – sentenced to six years for spying. He worked for US pharmaceutical giant Amgen in charge of research and development at their Asian operations. Caught in the crossfire between Beijing, the US and the EU, Zhang and…

Tribune News Service

A more aggressive FTC is starting to target drug mergers and industry middlemen

Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter.

Investors Business Daily

Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review

The Nasdaq and S&P 500 hit 2023 highs, fueled by AI-led chips and software names. But market leadership remains narrow.

Barchart

Stocks Undercut as Little Progress is seen in U.S. Debt Ceiling Talks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IU ) (QQQ ) closed up +0.09%. Stock indexes Tuesday settled mixed, with the Dow Jones...

The Independent UK

Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon

Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics

Barchart

Stocks Mixed as Debt Ceiling Talks Resume

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. U.S. stocks this morning are mixed, with the Dow...

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations